Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease

PURPOSE: High sustained antibody titers complicate many disorders treated with a therapeutic protein, including those treated with enzyme replacement therapy, such as Pompe disease. Although enzyme replacement therapy with alglucosidase alfa (Myozyme) in Pompe disease has improved the prognosis of t...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Banugaria, Suhrad G., Prater, Sean N., McGann, Judeth K., Feldman, Jonathan D., Tannenbaum, Jesse A., Bailey, Carrie, Gera, Renuka, Conway, Robert L., Viskochil, David, Kobori, Joyce A., Rosenberg, Amy S., Kishnani, Priya S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3744338/
https://ncbi.nlm.nih.gov/pubmed/23060045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2012.110
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items